OPSCC

Clinical trials for OPSCC explained in plain language.

Never miss a new study

Get alerted when new OPSCC trials appear

Sign up with your email to follow new studies for OPSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to shrink oral cancers before surgery

Disease control Recruiting now

This trial investigates whether adding ivonescimab—a drug that targets both PD-1 and VEGF—to standard chemotherapy can shrink locally advanced oral or oropharyngeal cancers before surgery. About 20 adults with resectable stage II–IVA disease will receive two cycles of the combina…

Matched conditions: OPSCC

Sponsor: Zhujiang Hospital • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

OPSCC

Get alerted when new OPSCC trials appear

New drug combo aims to shrink oral cancers before surgery